THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
THRX
Delisted
THRX was delisted on the 13th of February, 2024.
69 hedge funds and large institutions have $374M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
Holders
69
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$13.1M | |
| 2 | +$4.2M | |
| 3 | +$4.15M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$2.8M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$1.62M |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$2.87M | |
| 3 | -$1.63M | |
| 4 |
Walleye Capital
New York
|
-$1.59M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1.28M |